ZOLL Executive and Leadership Team

Eric Knudsen, the Chief Executive Officer at ZOLL, directs the overarching strategic vision for the organization. Overseeing global operations across North America, Europe, and Asia, the Chief Executive Officer ensures the alignment of medical device manufacturing with critical care requirements. This leadership role involves driving innovation in cardiopulmonary and respiratory technologies to maintain market leadership. By fostering collaboration between research teams and clinical partners, Eric Knudsen directly impacts the development of life-saving equipment. The Chief Executive Officer manages high-level resource allocation to support the expansion of automated external defibrillators and monitoring systems. Through rigorous focus on operational excellence, the Chief Executive Officer secures the long-term growth of the company. Knudsen maintains constant engagement with the Board to refine corporate objectives and enhance the delivery of medical solutions to healthcare providers worldwide, ultimately strengthening the position of the firm within the competitive healthcare sector.

Sean Rollman, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services at ZOLL, manages the financial health and operational efficiency of the Pittsburgh facility. Overseeing the integration of service delivery with fiscal planning, the Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services drives cost-effective manufacturing processes for life-saving devices. This leadership role involves balancing budgetary constraints with the high-performance requirements of critical care equipment production. By streamlining supply chain logistics and service operations, Sean Rollman directly impacts the profitability and reliability of the company. The Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services coordinates with regional leaders to ensure consistent service quality across North American operations. Through meticulous oversight of financial reporting and operational workflows, Rollman secures the stability of the site. The Chief Financial Officer & Zoll Site Leader (Pittsburgh) & Vice President, Operations & Services supports the broader corporate mission by optimizing resource utilization and enhancing service-level agreements for global healthcare clients.

Walter Hall, the Vice President Finance and Admin and Chief Financial Officer at ZOLL, directs the global financial strategy and administrative infrastructure. Overseeing corporate accounting, treasury functions, and internal controls, the Vice President Finance and Admin and Chief Financial Officer drives the fiscal discipline necessary for sustained medical technology innovation. This leadership role involves managing capital allocation to support the development of cardiopulmonary diagnostic tools and respiratory treatment systems. By implementing robust financial reporting frameworks, Walter Hall directly impacts the transparency and accountability of the organization. The Vice President Finance and Admin and Chief Financial Officer coordinates with executive leadership to assess the financial viability of new market expansions and product launches. Through strategic oversight of administrative processes, the Vice President Finance and Admin and Chief Financial Officer ensures that operational support aligns with the growth objectives of the company. Hall maintains the financial integrity of the firm, providing the necessary resources to sustain global operations and long-term research initiatives.

Shiri Shneorson, the President, ZOLL Itamar at ZOLL, leads the specialized division focused on respiratory diagnostic solutions and patient monitoring. Overseeing the commercialization of innovative diagnostic technologies, the President, ZOLL Itamar drives the adoption of advanced screening tools for sleep-related breathing disorders. This leadership role involves managing the transition of specialized medical devices into the broader portfolio of the company. By expanding the reach of diagnostic services into new clinical settings, Shiri Shneorson directly impacts the early detection and treatment of respiratory conditions. The President, ZOLL Itamar coordinates with global sales and marketing teams to penetrate international markets and increase the visibility of the division. Through strategic focus on clinical outcomes and user experience, the President, ZOLL Itamar ensures that the technology meets the evolving needs of healthcare providers. Shneorson fosters growth within the division by aligning product development with the overarching mission of improving patient care through superior diagnostic accuracy and accessible medical solutions.

Efrat Litman, the Chief Technology Officer at ZOLL, architects the technical roadmap for advanced life support equipment and diagnostic software. Overseeing the research and development pipeline, the Chief Technology Officer drives the integration of cutting-edge engineering into existing cardiopulmonary product lines. This leadership role involves managing complex technical teams to ensure compliance with global medical standards while pushing the boundaries of patient monitoring systems. By optimizing the design process for automated external defibrillators, Efrat Litman directly impacts the efficacy of critical care interventions. The Chief Technology Officer coordinates with product managers to translate clinical needs into scalable technological solutions. Through continuous evaluation of emerging medical trends, the Chief Technology Officer maintains the competitive edge of the company. Litman fosters a culture of innovation that supports the rapid deployment of new software solutions, ensuring that healthcare providers receive the most reliable tools for treating respiratory conditions across all global markets.